Intrommune Therapeutics Completes Last Patient Last Visit in the Phase 1 OMEGA Study for Peanut Allergy
25 juil. 2023 09h35 HE
|
Intrommune Therapeutics
NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food...
Sublingual Allergy Immunotherapy Market Size to Surpass US$ 1.02 billion by 2033 at a CAGR of 9.1%| Persistence Market Research
12 juin 2023 09h45 HE
|
Persistence Market Research
New York, June 12, 2023 (GLOBE NEWSWIRE) -- The sublingual allergy immunotherapy (SLIT) market has been experiencing steady growth in recent years due to increasing prevalence of allergies and...
Insights on the Allergy Immunotherapies Global Market to 2028: Rising Awareness of Allergy Immunotherapies, Elevating Income Levels and Increasing Healthcare Expenditure Drives Growth
21 févr. 2023 13h18 HE
|
Research and Markets
Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Intrommune Therapeutics Completes Enrollment in the Phase 1 OMEGA Study for Peanut Allergy
26 oct. 2022 09h35 HE
|
Intrommune Therapeutics
Observed only mild and transient adverse events, with no use of emergency epinephrine Observed 98.4% patient compliance to date with novel OMIT therapeutic modality Safely started patients on dose...
Intrommune Expands and Strengthens Senior Leadership Team
28 sept. 2022 09h35 HE
|
Intrommune Therapeutics
Appointment of Stuart Loesch as President Leverages His Strong Leadership Abilities and Extensive Expertise in Allergy and Pharmaceutical Development Appointment of William Berger, MD, MBA as Head of...
Food Allergy Market [2022-2027] | Global Market Size, Share, Growth Rate, Company Profiles, Demand, Key Finding, Revenue & Gross Margin, Market Drivers, Opportunities, Challenges and Risks Factors Analysis | Market Reports World
22 juin 2022 09h43 HE
|
Market Reports World
Pune, June 22, 2022 (GLOBE NEWSWIRE) -- Global Food Allergy Market (2022-2027) research report offers an in-depth analysis of market size, share, drivers, restraints, and so on. Moreover, this...
Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy
22 juin 2022 09h31 HE
|
Intrommune Therapeutics
Amendment to Extend Study Duration to 48 weeks New Maintenance Period Is Designed to Evaluate Safety of INT301 After Long-term Exposure NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Intrommune...
Global Food Allergy Pipeline Insight | Clinical Trials Evaluation Research Report 2022 by DelveInsight
20 juin 2022 12h00 HE
|
DelveInsight Business Research LLP
Las Vegas, USA, June 20, 2022 (GLOBE NEWSWIRE) -- Global Food Allergy Pipeline Insight | Clinical Trials Evaluation Research Report 2022 by DelveInsight Food Allergy Pipeline constitutes 35+...
Intrommune Therapeutics Names Nandini Murthy as Head of Regulatory
01 juin 2022 13h33 HE
|
Intrommune Therapeutics
NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a New York-based, clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and...
Worldwide Allergy Immunotherapy Industry to 2028 - Increasing Approval of Allergy Immunotherapy by Regulatory Authorities are Driving Growth
28 avr. 2022 07h23 HE
|
Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "Allergy Immunotherapy Market, by Treatment Type, by Allergy Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity...